Shionogi

A Unique Siderophore Cephalosporin
for the Treatment of Difficult-to-Treat
Gram-negative Infections

January 20, 2021

12:00 PM EST

Meet the Speaker

David Nicolau, PharmD
Director, Center for Anti-Infective Research and Development
Hartford Hospital
Hartford, Connecticut

Register Now
USUSL-0193 10/20